Pharma Pulse 3/8/24: Man Deliberately Got 217 COVID Shots, Navigating the Funding Slowdown While Securing Capital & more

Navigating the Current Funding Slowdown While Securing Capital

In this Pharmaceutical Commerce video interview, Emma Banks, CEO of ramarketing, discusses the biggest roadblocks to the widespread adoption of novel modalities, and how new biotech companies can navigate the current funding slowdown while securing the capital crucial for their success.

Telemedicine Usage Increased for Pediatric Asthma Following COVID-19 Pandemic

Individuals with persistent asthma and at least 1 complex comorbidity were more likely to use telemedicine, the results of the study showed.

A man deliberately got 217 Covid shots. Here’s what happened
One German man has redefined “man on a mission.” A 62-year-old from Magdeburg deliberately got 217 Covid-19 vaccine shots in the span of 29 months, according to a new study, going against national vaccine recommendations. That’s an average of one jab every four days.

Boehringer Ingelheim caps patient out-of-pocket costs for its inhaler portfolio at $35 per month​

Boehringer Ingelheim announced it will cap out-of-pocket costs at $35 per month for eligible patientsi for all the company’s inhaler products. Boehringer’s new program will dramatically decrease costs at the pharmacy counter for the most vulnerable patients, including those who are uninsured or underinsured. This reinforces the company’s long-standing commitment to ensure access to important medicines for patients.

@CencoraGlobal on Twitter/X:

In support of a healthier planet, we have committed to advancing environmental sustainability initiatives across our operations and supply chain. Some of these initiatives include sustainable and reusable packaging and implementing alternative fuel.. https://ow.ly/CwGL50QMYOV

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs